Drug intelligence / Profile preview

qingchang suppository (04656b)

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration
Rectal
01

Overview

Qingchang suppository (also known as Qing-Chang-Shuan or QCS) is a Traditional Chinese Medicine (TCM) preparation developed by Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine. It is specifically formulated for the treatment of mild to moderate active ulcerative proctitis, particularly for patients presenting with the 'damp-heat syndrome of the large intestine' according to TCM diagnostics. The formulation is a multi-herbal combination typically containing *Indigo naturalis* (Qingdai), *Radix Sanguisorbae* (Diyu), *Coptis chinensis* (Huanglian), *Phellodendron amurense* (Huangbai), and *Galla Chinensis* (Wubeizi). Its therapeutic effects are attributed to its anti-inflammatory and mucosal healing properties, which involve the inhibition of pro-inflammatory cytokines such as TNF-alpha, IL-1beta, and IL-6, as well as the modulation of the intestinal immune response and gut microbiota.

Brand names
Qingchang Suppository
Other names
Qingchang ShuanQing-Chang-Shuan
02

Targets

IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on qingchang suppository (04656b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on qingchang suppository (04656b).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call